Skip to Main Content

Paper Details

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Oncologist
3
2023
Ficlatuzumab, Gemcitabine, HGF, Metastatic Pancreatic Cancer, PDAC, Paclitaxel, Patients, albumin, c-Met, edema, ficlatuzumab, gemcitabine, hepatocyte growth factor, humanized, hypoalbuminemia, p-Met, paclitaxel, pancreatic ductal adenocarcinoma, patients, pts, tumor, tumor cell
Author NameAffiliation
Nora HorickMassachusetts General Hospital
Matthew B YurgelunDana-Farber Cancer Institute
Matthew B YurgelunHarvard Medical School
Koushik K DasWashington University School of Medicine
  • 1 - 4

Datasets

Release 1.2